| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,675 |
2,055 |
$137K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
840 |
675 |
$81K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
830 |
648 |
$32K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
773 |
658 |
$25K |
| 99199 |
Unlisted special service, procedure or report |
6,275 |
6,275 |
$18K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
785 |
654 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
156 |
109 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
862 |
733 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
458 |
323 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
34 |
30 |
$206.01 |
| 81003 |
|
29 |
24 |
$36.25 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
12 |
$29.81 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
15 |
12 |
$22.28 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
19 |
13 |
$12.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
106 |
72 |
$5.31 |
| 3074F |
|
253 |
226 |
$0.11 |
| 3078F |
|
240 |
210 |
$0.10 |
| 3079F |
|
35 |
30 |
$0.00 |